{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:53:57Z","timestamp":1792000437496,"version":"4.4.0"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec024\">\n<jats:title>Background<\/jats:title>\n<jats:p>Sepsis is a severe and potentially fatal systemic condition marked by excessive immune defense against infection. Within this research, we explored the serum concentration of S100A9 during hospital admission, aiming to assess its role and reliability as a viable biomarker for identifying septic shock and predicting mortality risk in sepsis. Furthermore, we explored whether combining S100A9 with conventional assessment tools could enhance diagnostic precision and prognostic accuracy, offering valuable insights to support early intervention and personalized treatment strategies for sepsis.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec025\">\n<jats:title>Methods<\/jats:title>\n<jats:p>This study comprised 575 participants overall, with sepsis patients classified into non-shock and shock groups based on the severity of their condition. Additionally, age- and gender-matched ICU control cohort and healthy control group were recruited to ensure wide applicability and strong comparability of the findings. Enzyme-linked immunosorbent assay utilized for detecting serum S100A9 levels in subjects within 24 hours of admission, ROC curves were used to evaluate the disease identification and prognostic analysis. Differences in survival outcomes among patients with varying levels of S100A9 expression were analyzed using the Kaplan-Meier method.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec026\">\n<jats:title>Results<\/jats:title>\n<jats:p>Serum S100A9 concentrations were elevated in septic patients upon admission. In the diagnosis of patients with septic shock, S100A9 performed similarly to APACHE II, and a considerable enhancement was noted in the sensitivity of detecting septic shock when S100A9 was combined with lactate and APACHE II. At the initiation of ICU stay, the area under the receiver operating characteristic curve (AUC) for the association between serum S100A9 levels and 28-day mortality was 0.78. This value surpassed the AUCs for IL-6 (0.66), procalcitonin (0.60), lactate (0.58) and C-reactive protein (0.47). Furthermore, septic patients with elevated serum S100A9 levels (\u2265 630.77 pg\/ml) exhibited lower survival rates compared to those with lower concentrations (&lt; 630.77 pg\/ml).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec027\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>S100A9 is a promising biomarker for diagnosing septic shock and forecasting clinical outcomes in patients with sepsis. In addition, S100A9 has good predictive efficacy for the risk of death in sepsis patients.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0325679","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T17:37:38Z","timestamp":1749231458000},"page":"e0325679","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["The role of S100A9 as a diagnostic and prognostic biomarker in septic shock"],"prefix":"10.1371","volume":"20","author":[{"given":"Yingxue","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0334-8999","authenticated-orcid":true,"given":"Xiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingwei","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"issue":"8","key":"pone.0325679.ref001","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"M Singer","year":"2016","journal-title":"JAMA"},{"key":"pone.0325679.ref002","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jcrc.2016.11.032","article-title":"Implications of the new sepsis definition on research and practice","volume":"38","author":"BC Peach","year":"2017","journal-title":"J Crit Care"},{"issue":"5","key":"pone.0325679.ref003","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S2213-2600(14)70061-X","article-title":"Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit","volume":"2","author":"J-L Vincent","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"2","key":"pone.0325679.ref004","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/01.CCM.0000194725.48928.3A","article-title":"Sepsis in European intensive care units: results of the SOAP study","volume":"34","author":"J-L Vincent","year":"2006","journal-title":"Crit Care Med"},{"issue":"10141","key":"pone.0325679.ref005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","article-title":"Sepsis and septic shock","volume":"392","author":"M Cecconi","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"pone.0325679.ref006","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1164\/rccm.201504-0781OC","article-title":"Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations","volume":"193","author":"C Fleischmann","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"pone.0325679.ref007","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13054-019-2329-5","article-title":"The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multi-centre derivation and validation study","volume":"23","author":"K Saeed","year":"2019","journal-title":"Crit Care"},{"issue":"10219","key":"pone.0325679.ref008","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study","volume":"395","author":"KE Rudd","year":"2020","journal-title":"Lancet"},{"issue":"7","key":"pone.0325679.ref009","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1097\/CCM.0b013e3181a02afc","article-title":"Biomarkers of sepsis","volume":"37","author":"JC Marshall","year":"2009","journal-title":"Crit Care Med"},{"issue":"2","key":"pone.0325679.ref010","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00134-022-06956-y","article-title":"How to use biomarkers of infection or sepsis at the bedside: guide to clinicians","volume":"49","author":"P P\u00f3voa","year":"2023","journal-title":"Intensive Care Med"},{"issue":"1","key":"pone.0325679.ref011","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4161\/viru.27393","article-title":"Rapid diagnosis of sepsis","volume":"5","author":"F Bloos","year":"2014","journal-title":"Virulence"},{"issue":"7","key":"pone.0325679.ref012","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2017.36","article-title":"The immunopathology of sepsis and potential therapeutic targets","volume":"17","author":"T van der Poll","year":"2017","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"pone.0325679.ref013","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1055\/s-0044-1787270","article-title":"Early diagnosis of sepsis: The role of biomarkers and rapid microbiological tests","volume":"45","author":"EP Plata-Menchaca","year":"2024","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"pone.0325679.ref014","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s13054-020-02993-5","article-title":"Biomarkers of sepsis: Time for a reappraisal","volume":"24","author":"C Pierrakos","year":"2020","journal-title":"Crit Care"},{"issue":"21","key":"pone.0325679.ref015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20215376","article-title":"The pathogenesis of sepsis and potential therapeutic targets","volume":"20","author":"M Huang","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"10","key":"pone.0325679.ref016","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/jth.13061","article-title":"New paradigms in sepsis: from prevention to protection of failing microcirculation","volume":"13","author":"J Hawiger","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"6","key":"pone.0325679.ref017","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"O Takeuchi","year":"2010","journal-title":"Cell"},{"issue":"3","key":"pone.0325679.ref018","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1128\/CVI.00636-12","article-title":"Targeting the \u201ccytokine storm\u201d for therapeutic benefit","volume":"20","author":"RV D\u2019Elia","year":"2013","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"pone.0325679.ref019","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/1871530315666150316123854","article-title":"S100A9 as a pharmacological target molecule in inflammation and cancer","volume":"15","author":"T Leanderson","year":"2015","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"pone.0325679.ref020","first-page":"637","article-title":"S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles","volume-title":"Calcium-binding proteins","author":"R Donato","year":"2001"},{"issue":"31","key":"pone.0325679.ref021","doi-asserted-by":"crossref","first-page":"18991","DOI":"10.1074\/jbc.R115.645085","article-title":"Nutritional immunity: S100 proteins at the host-pathogen interface","volume":"290","author":"JP Zackular","year":"2015","journal-title":"J Biol Chem"},{"issue":"14","key":"pone.0325679.ref022","doi-asserted-by":"crossref","first-page":"9496","DOI":"10.1074\/jbc.272.14.9496","article-title":"Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway","volume":"272","author":"A Rammes","year":"1997","journal-title":"J Biol Chem"},{"issue":"6","key":"pone.0325679.ref023","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.4049\/jimmunol.170.6.3233","article-title":"Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8\/A9 induce neutrophil chemotaxis and adhesion","volume":"170","author":"C Ryckman","year":"2003","journal-title":"J Immunol"},{"issue":"1","key":"pone.0325679.ref024","article-title":"DAMP molecule S100A9 acts as a molecular pattern to enhance inflammation during influenza A virus infection: role of DDX21-TRIF-TLR4-MyD88 pathway","volume":"10","author":"S-Y Tsai","year":"2014","journal-title":"PLoS Pathog"},{"issue":"11","key":"pone.0325679.ref025","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.4049\/jimmunol.1402301","article-title":"Proinflammatory proteins S100A8\/S100A9 activate NK cells via interaction with RAGE","volume":"194","author":"K Narumi","year":"2015","journal-title":"J Immunol"},{"issue":"8","key":"pone.0325679.ref026","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/s12276-022-00826-9","article-title":"Author correction: S100A9 in adult asthmatic patients: a biomarker for neutrophilic asthma","volume":"54","author":"QL Quoc","year":"2022","journal-title":"Exp Mol Med"},{"issue":"2","key":"pone.0325679.ref027","first-page":"1631","article-title":"Expression of S100 family proteins in neonatal rats with sepsis and its significance","volume":"8","author":"H Huang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"pone.0325679.ref028","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12931-021-01641-y","article-title":"S100A9 blockade prevents lipopolysaccharide-induced lung injury via suppressing the NLRP3 pathway","volume":"22","author":"B Zhao","year":"2021","journal-title":"Respir Res"},{"issue":"4","key":"pone.0325679.ref029","doi-asserted-by":"crossref","DOI":"10.1186\/cc11463","article-title":"Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor","volume":"16","author":"EJ Giamarellos-Bourboulis","year":"2012","journal-title":"Crit Care"},{"issue":"1","key":"pone.0325679.ref030","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13054-020-2830-x","article-title":"Monocytic HLA-DR expression kinetics in septic shock patients with different pathogens, sites of infection and adverse outcomes","volume":"24","author":"GP Leijte","year":"2020","journal-title":"Crit Care"},{"issue":"1","key":"pone.0325679.ref031","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/viru.27372","article-title":"Epidemiology of severe sepsis","volume":"5","author":"FB Mayr","year":"2014","journal-title":"Virulence"},{"issue":"18","key":"pone.0325679.ref032","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1056\/NEJMoa1401602","article-title":"A randomized trial of protocol-based care for early septic shock","volume":"370","author":"Investigators ProCESS","year":"2014","journal-title":"N Engl J Med"},{"issue":"12","key":"pone.0325679.ref033","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11908-021-00765-y","article-title":"Diagnostic challenges in sepsis","volume":"23","author":"CF Duncan","year":"2021","journal-title":"Curr Infect Dis Rep"},{"issue":"3","key":"pone.0325679.ref034","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/imm.13722","article-title":"Roles of S100A8, S100A9 and S100A12 in infection, inflammation and immunity","volume":"171","author":"P Xia","year":"2024","journal-title":"Immunology"},{"issue":"1","key":"pone.0325679.ref035","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41420-023-01766-7","article-title":"Immune dysregulation in sepsis: experiences, lessons and perspectives","volume":"9","author":"M Cao","year":"2023","journal-title":"Cell Death Discov"},{"issue":"1","key":"pone.0325679.ref036","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/imr.12499","article-title":"The immune system\u2019s role in sepsis progression, resolution, and long-term outcome","volume":"274","author":"MJ Delano","year":"2016","journal-title":"Immunol Rev"},{"key":"pone.0325679.ref037","article-title":"S100A8\/A9 in Inflammation","volume":"9","author":"S Wang","year":"2018","journal-title":"Frontiers in Immunology"},{"issue":"11","key":"pone.0325679.ref038","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.bcp.2006.05.017","article-title":"S100A8 and S100A9 in inflammation and cancer","volume":"72","author":"C Gebhardt","year":"2006","journal-title":"Biochem Pharmacol"},{"issue":"23","key":"pone.0325679.ref039","doi-asserted-by":"crossref","first-page":"12923","DOI":"10.3390\/ijms222312923","article-title":"Targeting S100A9 reduces neutrophil recruitment, inflammation and lung damage in abdominal sepsis","volume":"22","author":"Z Ding","year":"2021","journal-title":"Int J Mol Sci"},{"key":"pone.0325679.ref040","doi-asserted-by":"crossref","first-page":"149832","DOI":"10.1016\/j.bbrc.2024.149832","article-title":"S100A9 exacerbates sepsis-induced acute lung injury via the IL17-NF\u03baB-caspase-3 signaling pathway","volume":"710","author":"H Pei","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"pone.0325679.ref041","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.3390\/ijms24032112","article-title":"Deficiency of S100A9 alleviates sepsis-induced acute liver injury through regulating AKT-AMPK-dependent mitochondrial energy metabolism","volume":"24","author":"Y Zhang","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0325679.ref042","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12871-016-0212-3","article-title":"Prognostic significance of APACHE II score and plasma suPAR in Chinese patients with sepsis: a prospective observational study","volume":"16","author":"X Liu","year":"2016","journal-title":"BMC Anesthesiol"},{"issue":"1","key":"pone.0325679.ref043","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2215\/CJN.02510706","article-title":"Elevated plasma concentrations of IL-6 and elevated APACHE II score predict acute kidney injury in patients with severe sepsis","volume":"2","author":"LS Chawla","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"pone.0325679.ref044","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0002-9610(97)89552-9","article-title":"Serial blood lactate levels can predict the development of multiple organ failure following septic shock","volume":"171","author":"J Bakker","year":"1996","journal-title":"Am J Surg"},{"issue":"6","key":"pone.0325679.ref045","article-title":"Lactate level versus lactate clearance for predicting mortality in patients with septic shock defined by sepsis-3","volume":"46","author":"SM Ryoo","year":"2018","journal-title":"Crit Care Med"},{"issue":"3","key":"pone.0325679.ref046","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/MCC.0000000000000824","article-title":"Blood lactate levels in sepsis: in 8 questions","volume":"27","author":"J-L Vincent","year":"2021","journal-title":"Curr Opin Crit Care"},{"issue":"1","key":"pone.0325679.ref047","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13613-017-0252-y","article-title":"Multi-marker approach using procalcitonin, presepsin, galectin-3, and soluble suppression of tumorigenicity 2 for the prediction of mortality in sepsis","volume":"7","author":"GREAT Network","year":"2017","journal-title":"Ann Intensive Care"},{"issue":"1","key":"pone.0325679.ref048","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/s12879-021-06064-0","article-title":"Diagnostic value of neutrophil CD64, procalcitonin, and interleukin-6 in sepsis: a meta-analysis","volume":"21","author":"S Cong","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"1","key":"pone.0325679.ref049","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10096-022-04517-1","article-title":"28-day sepsis mortality prediction model from combined serial interleukin-6, lactate, and procalcitonin measurements: a retrospective cohort study","volume":"42","author":"Y Xie","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"pone.0325679.ref050","doi-asserted-by":"crossref","DOI":"10.1186\/cc7918","volume":"13","author":"H Khosravani","year":"2009","journal-title":"Critical care (London, England)"},{"issue":"8","key":"pone.0325679.ref051","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s11739-019-02196-z","article-title":"Prognostic value of serial lactate levels in septic patients with and without shock","volume":"14","author":"F Innocenti","year":"2019","journal-title":"Intern Emerg Med"},{"issue":"5","key":"pone.0325679.ref052","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00134-009-1402-y","article-title":"Is C-reactive protein a good prognostic marker in septic patients?","volume":"35","author":"J Silvestre","year":"2009","journal-title":"Intensive Care Med"},{"issue":"6","key":"pone.0325679.ref053","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/SHK.0b013e31819716fa","article-title":"Efficacy of procalcitonin in the early diagnosis of bacterial infections in a critical care unit","volume":"31","author":"A Nakamura","year":"2009","journal-title":"Shock"},{"issue":"3","key":"pone.0325679.ref054","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jinf.2021.01.019","article-title":"Interleukin-37 as a biomarker of mortality risk in patients with sepsis","volume":"82","author":"C Wu","year":"2021","journal-title":"J Infect"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0325679","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T17:37:50Z","timestamp":1749231470000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0325679"}},"subtitle":[],"editor":[{"given":"Chung-Ta","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":54,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0325679","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]}}}